The Department of Defense (DoD) is offering the Autism Idea Development Award to support innovative, high-impact research aimed at advancing the understanding of Autism Spectrum Disorder (ASD) and ultimately improving outcomes for individuals with autism. This grant is for studies involving human subjects, provided they do not constitute clinical trials. Applicants must provide preliminary data and demonstrate a sound scientific rationale. The award emphasizes significant impact and unique innovation in study concept, methods, or technology. Collaborative research is highly encouraged, allowing up to three Principal Investigators to work on a single project. The project must clearly articulate its innovative aspects and potential impact on ASD.
Opportunity ID: 51890
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-ARP-IDA |
| Funding Opportunity Title: | DoD Autism Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 16, 2010 |
| Last Updated Date: | Feb 17, 2010 |
| Original Closing Date for Applications: | Jul 28, 2010 |
| Current Closing Date for Applications: | Jul 28, 2010 |
| Archive Date: | Aug 27, 2010 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Idea Development Award mechanism was first offered in FY07. Since then, 109 Idea Development Award applications have been received, and 13 have been recommended for funding. The ARP Idea Development Award supports the development of innovative, high-impact ideas that advance the understanding of ASD and that ultimately will lead to improved outcomes for individuals with autism. Research involving human subject participation is permitted under this funding opportunity, but is restricted to studies without Clinical Trials. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Preliminary data relevant to the proposed research project is required. Preliminary data, unpublished results from the laboratory of the PI, research team, or collaborators named on this application, may be from outside of the ASD research field. Proposals should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature. Multiple PI Option: The FY10 ARP supports collaborative research in order to bring a new perspective to ASD research and/or facilitate progress in the field by combined effort. Therefore, up to three investigators may work on a single project, each of whom will be recognized as a PI and receive a separate award. One member of the team will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with the proposal. The other member(s) will be referred to as the Partnering PI(s). All the investigators must collaborate to submit a single proposal addressing a central problem or question in ASD research. It should be clear that all investigators have an equal level of intellectual input and effort. Multidisciplinary and multi-organizational projects are allowed. If the project is multi-organizational, PIs should include plans for communication between investigators at each organization. Additionally, participating organizations must be willing to resolve potential intellectual and material property issues, and to remove any barriers that might interfere with achieving high levels of cooperation to ensure successful completion of this award. Important aspects of the Idea Development Award are as follows: 1. Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of ASD and lead ultimately to improved outcomes for individuals with ASD. 2. Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not typically considered innovative. It is the responsibility of the PI to clearly and explicitly articulate the projects innovation and the potential impact on ASD. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Feb 17, 2010 | ||
| Feb 17, 2010 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-ARP-IDA |
| Funding Opportunity Title: | DoD Autism Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 16, 2010 |
| Last Updated Date: | Feb 17, 2010 |
| Original Closing Date for Applications: | Jul 28, 2010 |
| Current Closing Date for Applications: | Jul 28, 2010 |
| Archive Date: | Aug 27, 2010 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Idea Development Award mechanism was first offered in FY07. Since then, 109 Idea Development Award applications have been received, and 13 have been recommended for funding. The ARP Idea Development Award supports the development of innovative, high-impact ideas that advance the understanding of ASD and that ultimately will lead to improved outcomes for individuals with autism. Research involving human subject participation is permitted under this funding opportunity, but is restricted to studies without Clinical Trials. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Preliminary data relevant to the proposed research project is required. Preliminary data, unpublished results from the laboratory of the PI, research team, or collaborators named on this application, may be from outside of the ASD research field. Proposals should also be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature. Multiple PI Option: The FY10 ARP supports collaborative research in order to bring a new perspective to ASD research and/or facilitate progress in the field by combined effort. Therefore, up to three investigators may work on a single project, each of whom will be recognized as a PI and receive a separate award. One member of the team will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with the proposal. The other member(s) will be referred to as the Partnering PI(s). All the investigators must collaborate to submit a single proposal addressing a central problem or question in ASD research. It should be clear that all investigators have an equal level of intellectual input and effort. Multidisciplinary and multi-organizational projects are allowed. If the project is multi-organizational, PIs should include plans for communication between investigators at each organization. Additionally, participating organizations must be willing to resolve potential intellectual and material property issues, and to remove any barriers that might interfere with achieving high levels of cooperation to ensure successful completion of this award. Important aspects of the Idea Development Award are as follows: 1. Impact: The proposed research is expected to make an important and original contribution to advancing the understanding of ASD and lead ultimately to improved outcomes for individuals with ASD. 2. Innovation: Research deemed innovative may represent a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research may be innovative in study concept, research methods or technology, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not typically considered innovative. It is the responsibility of the PI to clearly and explicitly articulate the projects innovation and the potential impact on ASD. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@cdmrp.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-ARP-IDA |
| Funding Opportunity Title: | DoD Autism Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 17, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 28, 2010 |
| Archive Date: | Aug 27, 2010 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The ARP Resource Development Award mechanism is being offered for the first time in FY10. The ARP recognizes the critical need for improved resources to advance the field of ASD research and diagnosis, and to improve outcomes for individuals with ASD. The Resource Development Award supports product-driven research aimed at developing tools for use by the ASD research and/or clinical communities. These resources may include, but are not limited to, high-throughput assays, non-invasive imaging techniques, diagnostic tests, databases, devices, clinical tools, and model systems. Applicants should clearly articulate how the proposed product addresses an unmet need in the ASD research or clinical communities. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without Clinical Trials. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Preliminary data relevant to the proposed product development is allowed, but not required. Preliminary data, unpublished results from the laboratory of the PI, research team, or collaborators named on this application, may be from outside of the ASD research field. Proposals should be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature. Resource Distribution Plan: A plan describing the means by which the fully developed resource will be made available to the scientific and/or clinical community at reasonable or appropriate administrative costs, such as costs required for packaging and shipping the resource, should be addressed in the application. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@cdmrp.org |
Related Documents
Folder 51890 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 51890 Full Announcement-1 -> arp_fy10 ida pa_gg.pdf
Folder 51890 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Folder 51890 Revised Full Announcement-1 -> arp_fy10 ida pa_gg_revised.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00016469 | Feb 16, 2010 | Jul 28, 2010 | View |
Package 1
Mandatory forms
51890 RR_SF424_1_2-1.2.pdf
51890 PerformanceSite_1_4-1.4.pdf
Optional forms
51890 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
